International Patent: AMORPHOUS AND CRYSTALLINE FORMS OF 4-FLUORO-N-METHYL-N-(1-(4-(1-METHYL-1H- PYRAZOL-5-YL)PHTHALAZIN-1-YL)PIPERIDIN-4-YL)-2-(TRIFLUOROMETHYL)BENZAMIDE, AND USES THEREOF

GENEVA, Sept. 24 -- ENDEAVOR BIOMEDICINES, INC. filed a patent application (US2026/012357) for “AMORPHOUS AND CRYSTALLINE FORMS OF 4-FLUORO-N-METHYL-N-(1-(4-(1-METHYL-1H- PYRAZOL-5-YL)PHTHALAZIN-1-YL)PIPERIDIN-4-YL)-2-(TRIFLUOROMETHYL)BENZAMIDE, AND USES THEREOF”. With publication no. WO/2026/161698, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: A61K 31/40

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....